Unum Therapeutics stumbles on its Nasdaq debut, raising $69M and some transparency issues
Unum Therapeutics is limping out onto Nasdaq this morning after raising close to $70 million from the sale of its stock.
Unum priced 5.8 million …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
